Everence Capital Management Inc. Has $132,000 Holdings in Owens & Minor, Inc. (NYSE:OMI)

Everence Capital Management Inc. reduced its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 15.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,110 shares of the company’s stock after selling 1,900 shares during the quarter. Everence Capital Management Inc.’s holdings in Owens & Minor were worth $132,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its stake in Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after buying an additional 152,999 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Owens & Minor by 6.5% during the 3rd quarter. Franklin Resources Inc. now owns 61,223 shares of the company’s stock worth $961,000 after acquiring an additional 3,743 shares during the period. Geode Capital Management LLC boosted its position in shares of Owens & Minor by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,711,453 shares of the company’s stock worth $26,858,000 after acquiring an additional 13,164 shares in the last quarter. Vestcor Inc increased its stake in Owens & Minor by 624.2% in the third quarter. Vestcor Inc now owns 41,303 shares of the company’s stock valued at $648,000 after acquiring an additional 35,600 shares during the last quarter. Finally, Barclays PLC raised its position in Owens & Minor by 354.8% during the third quarter. Barclays PLC now owns 133,702 shares of the company’s stock valued at $2,099,000 after purchasing an additional 104,305 shares in the last quarter. Institutional investors own 98.04% of the company’s stock.

Insider Buying and Selling

In other news, CFO Jonathan A. Leon sold 5,282 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.59% of the stock is currently owned by company insiders.

Owens & Minor Stock Up 3.9 %

Owens & Minor stock opened at $14.38 on Friday. Owens & Minor, Inc. has a 12-month low of $11.42 and a 12-month high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company has a market capitalization of $1.11 billion, a PE ratio of -22.12, a PEG ratio of 0.48 and a beta of 0.46. The firm’s fifty day moving average is $13.17 and its 200 day moving average is $14.21.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, sell-side analysts predict that Owens & Minor, Inc. will post 1.49 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on OMI shares. UBS Group decreased their price target on Owens & Minor from $28.00 to $25.00 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. Citigroup decreased their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Robert W. Baird dropped their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Finally, Barclays decreased their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $18.50.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.